American Society of Hirudotherapy

Pubic Symphysis Dysfunction (Non-Pregnancy)

Investigational use for non-pregnancy-related pubic symphysis dysfunction including athletic osteitis pubis; anecdotal evidence.

Tier C — InvestigationalInvestigationalLast updated: 2026-05-26 · Reviewed by ASH Editorial Board

Patient Summary

Is this FDA-cleared for this use?
Not FDA-cleared for pubic symphysis dysfunction. FDA cleared medicinal leeches only for venous congestion in microsurgical reconstruction (K040187, 2004). Use here is Tier C investigational with case reports only.
What evidence exists?
Tier C (investigational). Only a handful of case reports exist. There are no controlled trials. Non-pregnancy pubic symphysis dysfunction (osteitis pubis, adductor enthesopathy) is most common in athletes. Evidence-based management includes rest, NSAIDs, progressive return-to-sport protocols, adductor and core strengthening, and image-guided corticosteroid injection for refractory cases. Pregnancy-related symphysis pubis dysfunction is a separate clinical entity managed by physiotherapy, pelvic support belt, and obstetric care, and is a relative contraindication for leech therapy.
Main risks
  • Bleeding from bite sites for 6 to 24 hours after detachment
  • Bruising and tenderness over the pubic region for 5 to 14 days
  • Local skin infection or Aeromonas infection (region near urogenital structures)
  • Allergic reaction to leech saliva
  • Worsening of adductor strain or pubic pain
  • Delay of structured rehabilitation and return-to-sport progression
  • Failure to identify pubic osteomyelitis if infection workup is incomplete
  • Reproductive concerns if leech is placed too close to midline urogenital structures
Who should not consider this
  • Pregnant patients (especially in the third trimester)
  • Patients with active urogenital or pelvic infection
  • Patients with suspected or confirmed pubic symphysis osteomyelitis
  • Patients without imaging confirming the diagnosis (rule out stress fracture, neoplasm)
  • Patients on anticoagulants or with severe anemia
  • Patients who have not engaged with structured rehabilitation
What to ask your clinician
  • Has imaging (MRI or bone scan) confirmed the diagnosis and excluded osteomyelitis or stress fracture?
  • Have I completed at least 8 to 12 weeks of structured adductor and core rehabilitation?
  • Has image-guided corticosteroid injection been considered?
  • Where exactly will the leech be placed — confirm it is lateral to midline urogenital structures?
  • What is the realistic expected benefit, given case reports only?
  • What is the practitioner's experience with this indication?
When to seek urgent care
  • Fever above 38.0 C / 100.4 F, chills, or rigors (rule out osteomyelitis or pelvic infection)
  • Sudden severe groin or pubic pain or inability to bear weight
  • Visible bleeding from the urethra or vagina
  • Spreading redness, warmth, pus, or red streaks at any bite site
  • Bleeding from a bite site lasting more than 24 hours
  • Difficulty urinating or new urinary symptoms

What this does NOT mean

  • It does not substitute for rehabilitation, NSAIDs, or corticosteroid injection.
  • It is not appropriate during pregnancy or breastfeeding.
  • It does not treat osteomyelitis, which requires culture-directed antibiotics.
  • Only case reports exist; benefit beyond placebo or natural-history improvement is uncertain.

Clinical Profile

Category
musculoskeletal
ICD-10
M26.30, M25.88, M85.30
Safety tier
medium

Evidence Summary

Non-pregnancy pubic symphysis dysfunction is most common in athletes (osteitis pubis, adductor enthesopathy). Conventional management includes rest, NSAIDs, and progressive return-to-sport protocols. Pregnancy-related symphysis pubis dysfunction (SPD) is a separate clinical entity and a relative contraindication during the third trimester. No controlled clinical trial or published case series of leech therapy for pubic symphysis dysfunction has been reported; any use is investigational and mechanistic only, and it should not displace evidence-based conservative care.

Treatment specifics

How many leeches, where they are placed, how long a session lasts, and whether to repeat are clinical decisions made by a qualified provider under institutional protocol — not something to self-administer. Discuss the specifics with a clinician experienced in medicinal leech therapy. (Clinicians: switch the audience selector in the top bar to “Clinician” to view protocol detail.)

Key Trials

  1. Mehta S et al. (2020)0

Contraindications

  • Active anticoagulant therapy (warfarin INR >2.0, DOACs, heparin)
  • Hemophilia or other bleeding disorder
  • Severe anemia (Hb <10 g/dL)
  • Active bacteremia or sepsis
  • Known hypersensitivity to leech salivary proteins
  • Pregnancy (relative — first/third trimester)
  • Immunocompromised state with severe neutropenia
  • Pregnancy (especially third trimester)
  • Active urogenital infection
  • Pubic symphysis osteomyelitis

Related Conditions

This website provides educational information and does not constitute medical advice, diagnosis, or treatment recommendations. Medicinal leech therapy carries clinically meaningful risks and should be performed only by qualified clinicians under institutionally approved protocols. FDA 510(k) clearance for medicinal leeches is limited to specific indications; investigational and off-label discussions are labeled accordingly. For patient-specific guidance, consult a qualified healthcare provider.

Pubic Symphysis Dysfunction (Non-Pregnancy) — Hirudotherapy Evidence | ASH